Mon.Jul 31, 2023

article thumbnail

Certain Factors May Increase Long COVID Risk in Children

Drug Topics

Children who tested positive were more likely to report long COVID symptoms at 90 days than children who tested negative.

247
247
article thumbnail

A pharma banking on the success of past blockbusters

PharmaVoice

180 Life Sciences is on a mission to see if the anti-TNF technology that produced a blockbuster could work for a range of other conditions.

246
246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Vitamin D Could Provide Benefit to Patients With Psoriasis

Drug Topics

Researchers recommend patients with psoriasis and their dermatologists discuss whether taking a vitamin D supplement is right for them.

247
247
article thumbnail

Patients With HIV Have Low Risk of End-Stage Renal Disease After Donating Kidney

Pharmacy Times

Patients with HIV can donate a kidney to others with HIV who have a low risk of developing end-stage renal disease or other kidney problems for 2 to 4 years following donation.

123
123
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Acute Myeloid Leukemia Therapy Approved by FDA

Drug Topics

Quizartinib (Vanflyta) is an oral inhibitor of FLT3, and it specifically targets FLT3-ITD mutations, which drive cancer growth and contribute to increased risk of relapse and shorter overall survival.

FDA 247
article thumbnail

The Not So New Role of Pharmacists: No Longer an Overlooked Health Care Provider

Pharmacy Times

Pharmacists are critically important in care delivery in their ability to influence patient success, patient-reported outcomes, and quality of life while reducing the burden on physicians and their clinical support teams.

123
123

More Trending

article thumbnail

Restricted Eating Shows Similar Improvements in Blood Sugar as Reducing Calories for Type 2 Diabetes

Pharmacy Times

Individuals who restrict their eating to between 12 pm and 8 pm daily lost more weight than those who reduced overall calorie intake for type 2 diabetes.

123
123
article thumbnail

Medifast debuts Optavia Active

Drug Store News

Medifast, a health and wellness company known for its habit-based and coach-guided lifestyle solution Optavia, is unveiling a new product line, dubbed Optavia Active.

98
article thumbnail

Sleep Disturbance Possible Adverse Effect of Cardiac Disease, New Study Finds

Pharmacy Times

The lowering melatonin levels in patients with heart disease is one example of how heart conditions can influence systems throughout the body.

123
123
article thumbnail

Vivek Ramaswamy wants to ‘gut’ the FDA. His claims don’t hold up to scrutiny

STAT

STAT readers know Vivek Ramaswamy from his time as the founder of the biotech conglomerate Roivant — and for his role in some of its various subsidiaries and spinoffs. Of course, the world now knows Ramaswamy for a very different reason: He’s running for president, and has made the cut to participate in the first debate of the Republican primary.

FDA 98
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Merck Announces Positive Results From Phase 3 Pneumococcal Vaccine Trials

Pharmacy Times

If approved, the V116 vaccine would be the first pneumococcal conjugate vaccine specifically designed for adults.

Vaccines 123
article thumbnail

STAT+: Gene therapy is in crisis. For nine hours, the field’s leading minds looked for a solution

STAT

WASHINGTON — Jennifer Puck has successfully treated 10 children with a gene therapy for a fatal disorder that decimates their immune system. But she has no idea how to get her drug approved and frankly is running out of ideas. “I wish I had a clue about where to go from here,” said Puck, an immunologist at University of California, San Francisco, from a plush chair above Union Station.

article thumbnail

A Dab of MAB: Lecanemab, Aducanumab vs Standard of Care Treatment for Alzheimer Disease

Pharmacy Times

Pharmacists play a key role in the management of modern monoclonal antibody treatments for Alzheimer disease.

122
122
article thumbnail

Opinion: I’m a tick biologist whose body seems to kill off ticks

STAT

Sometimes people call me “the tick guy,” but I’m a mammal guy by training. Although I respect ticks, I don’t fear them, especially after developing an immunity that kills them when they try to bite me. Back in 1991 I joined some colleagues at the Cary Institute in New York on a project devoted to understanding the responses by eastern deciduous forests in the United States to stress and damage.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Signify Health launches in-home testing for chronic kidney disease

Fierce Healthcare

Signify Health is expanding its services with the addition of a new in-home testing option for chronic kidney disease. | Signify Health is expanding its services with the addition of a new in-home testing option for chronic kidney disease.

98
article thumbnail

Opinion: New attacks on the drug industry would have made my breakthrough sickle cell treatment impossible

STAT

I was born in Alabama in the Jim Crow South, one of eight siblings in a hard-working Black farming community. Our family doctor, a leading figure in the community, inspired me to follow in his footsteps and help people in need. Years later, while working as a physician in Massachusetts, I was appalled to observe how many medicines failed to benefit society’s most vulnerable, in particular people of color.

98
article thumbnail

Elevance Health to rebrand Amerigroup plans as Wellpoint in 6 states

Fierce Healthcare

Last year, Blues plan giant Anthem unveiled a corporate rebrand as Elevance Health, a move it said better illustrated its ambitions to be more than just a health plan. | The company is updating the branding for its Amerigroup segment to Wellpoint in a bid to better align the government insurance business with its push toward whole health.

article thumbnail

As wildfires burn, scientists race to understand the health dangers of prolonged exposure

STAT

More than 120 million Americans — one-third of the U.S. population — have been living under air quality alerts this summer, with citizens in New York City, Chicago, and Detroit at times experiencing some of the unhealthiest air in the world. The hazy conditions, fed by an unprecedented surge in Canadian wildfires likely fueled by climate change, has grounded planes, canceled outdoor sporting events, and filled emergency rooms with asthma patients.

98
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Subtl stacks makeup essentials together with Stak 2.0

Drug Store News

Subtl’s Stak 2.0 allows shoppers to build their own custom stack with essentials that fit their daily makeup routines, the company said.

98
article thumbnail

National panel will explore requiring free Covid tests

STAT

WASHINGTON — The U.S. Preventive Services Task Force will discuss recommending Covid-19 screening, the first step in requiring insurers to permanently cover the tests at no cost to patients. The national panel of experts will convene and “determine whether and how Covid-19 screening might be considered within the Task Force’s scope,” chair Michael Barry wrote in a letter to Sen.

article thumbnail

Magnetic tentacles represent possible novel approach for less invasive lung cancer treatment

Hospital Pharmacy Europe

The use of magnetic tentacles offer a novel therapeutic and targeted approach for minimally invasive lung cancer treatment, according to researchers from the University of Leeds. The researchers developed a tiny, magnetically operated robot that is capable of travelling deep into the lungs and able to detect and treat the first signs of cancer. Their approach makes use of a 2.4 mm diameter, ultra-soft, patient-specific magnetic catheter – or tentacle – which can be delivered from the end of a st

article thumbnail

STAT+: New safety details link Apellis eye drug to rare cases of blindness. Cause still unknown

STAT

Five elderly people have been blinded by a severe side effect after receiving injections of a newly approved treatment for eye disease from Apellis Pharmaceuticals. The frequency of this side effect — a severe type of eye inflammation — is low but its cause remains unknown. The new safety information related to the Apellis drug, called Syfovre, was presented Saturday by a committee of eye disease experts at the annual meeting of the American Society of Retinal Specialists (ASRS).

98
article thumbnail

Removing snags in cell and gene therapy manufacturing processes with robotics

Pharmaceutical Technology

Deploying robots in pharmaceutical manufacturing will remove snags in cell and gene therapies and enable breakthroughs

98
article thumbnail

STAT+: Flow Neuroscience shows promising results in trial of brain-stimulation headset for depression

STAT

Flow Neuroscience, a small Swedish company treating depression with brain-stimulating headsets, released early data on Monday showing that its device relieved depressive symptoms in clinical trials.  The company has not yet formally written up the data for a journal. But Flow leaders have included the data in an application for Food and Drug Administration approval and provided STAT with topline data ahead of releasing them publicly.

FDA 98
article thumbnail

~Pourri kicks off nostalgic camp funk campaign

Drug Store News

The campaign highlights humorous, relatable stories that will run across social media and streaming platforms, the company said.

98
article thumbnail

STAT+: Medicare wants to improve Alzheimer’s care, but sidesteps drug prices

STAT

WASHINGTON — Medicare announced Monday a pilot program aimed at improving dementia care and reducing the strain on unpaid caregivers, but it does not deal with controlling the price of new Alzheimer’s drugs. The pilot is voluntary. Physician practices that participate will get a lump-sum payment for each dementia patient in their care.

98
article thumbnail

Strategies to Boost Your Pharmacy’s Front-of-House Sales

Digital Pharmacist

To boost your pharmacy’s storefront sales, the best place to start is by understanding the importance of pharmacy marketing and making sure you are taking the necessary steps to optimize your front-end sales. With the right strategies, you can increase customer loyalty, drive more sales, and establish yourself as a reliable pharmacy in your community.

article thumbnail

Personalised mRNA cancer vaccines: Moderna and Merck & Co versus BioNTech and Roche

Pharmaceutical Technology

While messenger ribonucleic acid (mRNA)-based cancer vaccines have been in development for decades, their development had languished.

article thumbnail

Food Lion upgrades 47 stores across North Carolina

Drug Store News

Food Lion has enhanced the customer shopping experience with remodeled stores in Greenville, Jacksonville and New Bern, N.C.

98
article thumbnail

Tenet Healthcare banks $123M profit in Q2 thanks to 'robust' ASC, inpatient volumes

Fierce Healthcare

Tenet Healthcare beat the street in the second quarter, reporting Monday $123 million in net income thanks to higher volumes and revenues across its ambulatory care segment. | The for-profit system beat the street with net operating revenues up 9.5% year over year, prompting an increase to 2023 guidance.

98
article thumbnail

Can dogs take Zyrtec?

The Checkup by Singlecare

Does your dog constantly scratch its neck or gnaw at its legs? It could be a sign they have an itch caused by an allergic reaction to grass, mold, dust mites, an insect bite, or another source. Giving your dog Zyrtec may help ease your its itchy skin and other symptoms. If you experience seasonal allergies, you know what kind of relief your go-to allergy medication provides.

Dosage 98
article thumbnail

Purdue bankruptcy case elevated to SCOTUS

pharmaphorum

Purdue bankruptcy case elevated to SCOTUS Phil.

98
article thumbnail

CDKL5 deficiency-associated seizure treatment approved in EU

European Pharmaceutical Review

The first treatment for children and adolescents who have epileptic seizures associated with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) has been approved in the EU by the European Commission (EC). EC has granted approval of ZTALMY ® (ganaxolone) oral suspension as adjunctive treatment in CDD patients from two to 17 years old. The European regulatory body’s decision “represents a significant milestone” according to Dr Scott Braunstein, Chairman and Chief Executive Off